2. Academic Validation
  3. A Near-Infrared Photoactivatable, Brain-Penetrant Prodrug of the Prolyl Hydroxylase Inhibitor Vadadustat for Neuroprotection in Ischemic Stroke

A Near-Infrared Photoactivatable, Brain-Penetrant Prodrug of the Prolyl Hydroxylase Inhibitor Vadadustat for Neuroprotection in Ischemic Stroke

  • J Med Chem. 2026 May 28;69(10):12702-12721. doi: 10.1021/acs.jmedchem.6c01014.
Ke Li 1,  Tiande Bing 2,  Yikai Mo 2,  Wenxuan Wang 2,  Jihong Xing 1,  Le Yang 2,  Danni Ao 2,  Zhihong Li 2,  Fulai Yang 2,  Yue Wu 2,  Xiaojin Zhang 2
Affiliations

Affiliations

  • 1 Department of Emergency Medicine, The First Hospital of Jilin University, Changchun 130021, China.
  • 2 Jiangsu Key Laboratory of Drug Design and Optimization, and Department of Chemistry, School of Science, China Pharmaceutical University, Nanjing 211198, China.
PMID: 42068294 DOI: 10.1021/acs.jmedchem.6c01014
Abstract

Ischemic stroke is a leading cause of mortality and disability with limited therapeutic options. Activation of the hypoxia-inducible factor (HIF) pathway via knockout of the neuronal prolyl hydroxylase domain (PHD) enzyme has shown neuroprotective potential. However, most PHD inhibitors exhibit poor brain penetration due to their high intrinsic polarity, particularly the presence of carboxyl groups. Here, we reported a near-infrared (NIR)-activated photocaged prodrug (11) that masks the acidic pharmacophore of Vadadustat (5) to facilitate BBB penetration and enable spatiotemporally controlled drug release in the brain upon NIR irradiation. Prodrug 11 significantly attenuated cellular injury in HT22 cells under oxygen-glucose deprivation/reoxygenation (OGD/R) following NIR irradiation. Moreover, in a mouse model of cerebral ischemia-reperfusion (I/R), prodrug 11 reduced infarct volume and brain edema, and promoted neurological recovery. These findings highlight a photoactivatable, brain-penetrant prodrug strategy for spatiotemporally controlled neuroprotection.

Figures
Products